BPC-157
Body Protection Compound; a stable gastric pentadecapeptide studied for tissue repair and gastroprotection.
TB-500
Synthetic fraction of Thymosin Beta-4; promotes actin binding, cell migration, and tissue regeneration.
Semaglutide
GLP-1 receptor agonist with 94% homology to native GLP-1, studied extensively for metabolic and neuroprotective effects.
CJC-1295
Modified GHRH analogue with extended half-life via DAC technology; research focuses on pulsatile GH release.
Ipamorelin
Selective ghrelin receptor agonist; one of the most selective GHSs studied with minimal off-target effects.
AOD-9604
Modified fragment of human growth hormone (176-191) studied for adipose regulation without IGF-1 effects.
GHK-Cu
Copper-binding tripeptide naturally present in plasma; researched for wound healing, anti-inflammatory, and regenerative properties.
Hexarelin
Synthetic hexapeptide GHS with potent GH-releasing activity; studied alongside cardiovascular protective effects.
Sermorelin
Synthetic analogue of GHRH (1-29); the shortest fully active fragment of GHRH studied clinically.
Tesamorelin
Stabilized GHRH analogue with FDA approval for HIV-associated lipodystrophy; studied for visceral adiposity.
PT-141
Bremelanotide; melanocortin receptor agonist studied for sexual dysfunction in both male and female models.
Melanotan II
Cyclic lactam analogue of alpha-MSH; non-selective melanocortin agonist studied for tanning and sexual function.
Thymosin Alpha-1
Naturally occurring 28 amino acid peptide from thymosin fraction 5; primary immune modulator in research.
Epithalon
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied as a telomerase activator and pineal gland regulator.
MOTS-c
Mitochondrial-derived peptide encoded in the 12S rRNA; emerging research in metabolic homeostasis and exercise mimetics.